A white paper from Qiagen
This white paper from Qiagen describes tracking ERBB2-targeted therapies using COSMIC Actionability, a feature within the Catalogue of Somatic Mutations in Cancer that indicates the availability of drugs that target mutations in cancer and tracks the progress of clinical studies towards making new drugs available.
Offered Free by: Qiagen
See All Resources from: Qiagen